跳至主要内容
临床试验/NCT01360346
NCT01360346Unknown3 期

Multicentric, Single Blind, Randomized Controlled Trial on Enteral Sedation Versus Intravenous Sedation in Critically Ill High-risk ICU Patients

University of Milan2 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
3 期
入组人数
300
试验地点
2
主要终点
Percent of efficacy, measured by observed RASS = desired RASS ± 1.

研究概览

简要总结

Recent studies suggest the employment of 'conscious' sedation (1) for critically high - risk patients (2), showing more efficacy then deep sedation (3). The investigators want to compare intravenous injection versus enteral sedative drugs administration, purposing to maintain a 'conscious' sedation level compatibly with the needed cares, invasive procedures, and medical and nursing surveillance.

详细描述

Recent studies suggest the employment of 'conscious' sedation for critically high - risk patients (2), showing more efficacy then deep sedation (3). From this point of view it's important to consider both the choice of sedative drugs and the way to administer them to maintain the constant 'conscious' sedation level that the investigators wanted.

This research compares two different procedures for sedation therapy: through a randomized and blind controlled trial the interventional group will collect patients receiving sedatives from enteral way (4, 5, 6). In the control arm, sedation administration forecasts intravenous injection (7), recognised like the best practice in the most of intensive care units of the world.

To consider two different clinical approach for administration the investigators have to use different molecules: in the control arm propofol and midazolam will be continuously administered through intravenous injection with daily suspension (7); in the intervention arm the investigators will administer melatonin like a physiological hypnotic inductor (6), the continuous 'conscious' sedation will be maintained through hydroxyzine and eventually lorazepam (4), and all the active principles will be given by enteral administration.

The goal of the study is to compare intravenous injection versus enteral sedative drugs administration, analysing their efficacy and the feasibility to maintain constant the appropriate sedation level (RASS measured = RASS wished ±1) (8) in high - risk patients admitted in Intensive Care Unit (2), purposing to conserve a 'conscious' sedation level compatibly with the needed cares, invasive procedures, and medical and nursing surveillance.

MATERIALS AND METHODS Prospective, randomized and controlled multicentric, single blind trial. Participant ICU centres: San Paolo MI (Iapichino), Policlinico MI (Gattinoni) , Fatebenefratelli MI (Cigada), Niguarda MI (De Gasperi), Desio (Ronzoni), Legnano (Radrizzani), Monza (Pesenti), Belluno (Mazzon), Lugano (Malacrida), Modena (Rambaldi), Torino (Livigni), Asti (Cardellino).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • High Risk Patients (Ventilation days assessment >3, SAPS II >32).
  • Until 24 h after ICU admission
  • Age > 18 years

排除标准

  • Neurosurgical patients
  • Allergy to medications used in the study
  • CNS diseases (epilepsy, ictus, dementia, anoxic coma...)
  • Liver encephalopathy (Child C)
  • Previous psychiatric or cognitive pathology
  • Absolute contraindications to use enteral route (acceptable NGT, digiunostomy, ileostomy)
  • Pregnant patients or in breast-feeding
  • DNR patients

结局指标

主要结局

Percent of efficacy, measured by observed RASS = desired RASS ± 1.

时间窗: One year

次要结局

  • Sedation protocol effectiveness: percentage of "protocol violation days" on the total of ICU days.(One year)
  • Delirium and coma free days (respectively negative CAM-ICU and RASS > - 3 in all daily observations until 28° ICU day) (11)(One year)
  • Ventilation free days (12)(One year)
  • Nursing evaluation of sedation adequacy (communication skills, cooperation, environment tolerance) (13)(One year)
  • Overall ICU and hospital mortality, absolute mortality after 1 year from ICU discharge.(24 months)
  • Sedative drugs costs.(One year)
  • Indirect inefficacy markers(One year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giovanni Mistraletti

University Researcher

University of Milan

研究点 (2)

Loading locations...

相似试验